Search Results - "Flucke, U.E"

9410 IGF1R expression in Ewing's sarcoma by Versleijen-Jonkers, Y.M.H, van de Luijtgaarden, A.C.M, Roeffen, M.H.S, Schreuder, H.W.B, Flucke, U.E, van der Graaf, W.T.A

Get full text

2101 Evaluation of neoadjuvant chemotherapy with FDG PET/CT and MRI in adult patients with Ewing's sarcoma (ES) and osteosarcoma (OS): beyond RECIST by van de Luijtgaarden, A.C.M, de Rooy, J.W.J, Postema, J.W.A, de Geus-Oei, L.F, Flucke, U.E, Schreuder, H.W.B, Oyen, W.J.G, van der Graaf, W.T.A

Get full text

DNA methylation profiles of angiosarcoma subtypes by Weidema, M.E., de Jong, E., Koelsche, C., Desar, I.M.E., Hillebrandt-Roeffen, M.H.S., van der Graaf, W.T., Versleijen-Jonkers, Y.M.H., Von Deimling, A., Flucke, U.E.

Get full text

1711P - DNA methylation profiles of angiosarcoma subtypes by Weidema, M.E., de Jong, E., Koelsche, C., Desar, I.M.E., Hillebrandt-Roeffen, M.H.S., van der Graaf, W.T., Versleijen-Jonkers, Y.M.H., Von Deimling, A., Flucke, U.E.

“…Angiosarcoma (AS) is a rare malignancy with a heterogeneous clinical presentation and genetic background. Different clinical AS subtypes can be envisaged,…”
Get full text

Targeting angiosarcomas of the soft tissues: A challenging effort in a heterogeneous and rare disease by Weidema, M.E., Versleijen-Jonkers, Y.M.H., Flucke, U.E., Desar, I.M.E., van der Graaf, W.T.A.

“…[Display omitted] Angiosarcomas are rare malignant tumors with a heterogeneous clinical presentation and generally poor prognosis. It has been difficult to…”
Get full text

Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands by Boon, E., Valstar, M.H., van der Graaf, W.T.A., Bloemena, E., Willems, S.M., Meeuwis, C.A., Slootweg, P.J., Smit, L.A., Merkx, M.A.W., Takes, R.P., Kaanders, J.H.A.M., Groenen, P.J.T.A., Flucke, U.E., van Herpen, C.M.L.

“…•We evaluated 31 patients with secretory carcinoma of salivary glands.•Clinical outcomes were generally good with 5- and 10-year overall survival of 95%.•One…”
Get full text

Mammary analogue secretory carcinoma (MASC): clinical characteristics in 28 ETV6-NTRK3 fusion gene confirmed patients by Boon, E., Valstar, M.H., van der Graaf, W.T.A., Bloemena, E., Willems, S.M., Meeuwis, C.A., Smit, L.A., Merkx, M.A.W., Takes, R.P., Flucke, U.E., Herpen, C.M.L.

Get full text

Overexpression of the c-MET proto-oncogene in salivary duct carcinoma patients by Herpen, C.M.L., Boxtel, W., Flucke, U.E., Bloemena, E., Boon, E., Verhaegh, G., Aalders, M.W., Jonker, M.A., Schalken, J., Versleijen-Jonkers, Y.M.H.

Get full text

The Role of Axl in Ewing Sarcoma by Fleuren, E.D.G., van der Graaf, W.T.A., Roeffen, M.H.S., Flucke, U.E., Schreuder, B., Boerman, O., Versleijen-Jonkers, Y.M.H.

Get full text

1456PTHE ROLE OF AXL IN EWING SARCOMA by Fleuren, E.D.G., van der Graaf, W.T.A., Roeffen, M.H.S., Flucke, U.E., Schreuder, B., Boerman, O., Versleijen-Jonkers, Y.M.H.

“…Abstract Aim: Ewing sarcoma (ES) is an aggressive form of primary bone cancer affecting mainly children and young adults. Despite intensive multimodal…”
Get full text

Simultaneous Targeting of the Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Anaplastic Lymphoma Kinase (ALK) in Embryonal and Alveolar Rhabdomyosarcoma by van Gaal, J.C., Versleijen-Jonkers, Y.M.H., Roeffen, M.H.S., Flucke, U.E., van der Heijden, G., Suurmeijer, A.J.H., De Bont, E.S.J.M., van der Graaf, W.T.A.

Get full text